PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Moretti, A.* ; Fonteyne, L.* ; Giesert, F. ; Hoppmann, P.* ; Meier, A.B.* ; Bozoglu, T.* ; Baehr, A.* ; Schneider, C.M.* ; Sinnecker, D.* ; Klett, K.* ; Fröhlich, T.* ; Rahman, F.A.* ; Haufe, T.* ; Sun, S.* ; Jurisch, V.* ; Kessler, B.* ; Hinkel, R.* ; Dirschinger, R.* ; Martens, E.* ; Jilek, C.* ; Graf, A.* ; Krebs, S.* ; Santamaria, G.* ; Kurome, M.* ; Zakhartchenko, V.* ; Campbell, B.* ; Voelse, K.* ; Wolf, A.* ; Ziegler, T.* ; Reichert, S.* ; Lee, S.* ; Flenkenthaler, F.* ; Dorn, T.* ; Jeremias, I. ; Blum, H.* ; Dendorfer, A.* ; Schnieke, A.* ; Krause, S.* ; Walter, M.C.* ; Klymiuk, N.* ; Laugwitz, K.L.* ; Wolf, E.* ; Wurst, W. ; Kupatt, C.*

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.

Nat. Med. 26, 207-214 (2020)
Postprint Forschungsdaten DOI PMC
Open Access Green
Frameshift mutations in the DMD gene, encoding dystrophin, cause Duchenne muscular dystrophy (DMD), leading to terminal muscle and heart failure in patients. Somatic gene editing by sequence-specific nucleases offers new options for restoring the DMD reading frame, resulting in expression of a shortened but largely functional dystrophin protein. Here, we validated this approach in a pig model of DMD lacking exon 52 of DMD (DMDΔ52), as well as in a corresponding patient-derived induced pluripotent stem cell model. In DMDΔ52 pigs1, intramuscular injection of adeno-associated viral vectors of serotype 9 carrying an intein-split Cas9 (ref. 2) and a pair of guide RNAs targeting sequences flanking exon 51 (AAV9-Cas9-gE51) induced expression of a shortened dystrophin (DMDΔ51-52) and improved skeletal muscle function. Moreover, systemic application of AAV9-Cas9-gE51 led to widespread dystrophin expression in muscle, including diaphragm and heart, prolonging survival and reducing arrhythmogenic vulnerability. Similarly, in induced pluripotent stem cell-derived myoblasts and cardiomyocytes of a patient lacking DMDΔ52, AAV6-Cas9-g51-mediated excision of exon 51 restored dystrophin expression and amelioreate skeletal myotube formation as well as abnormal cardiomyocyte Ca2+ handling and arrhythmogenic susceptibility. The ability of Cas9-mediated exon excision to improve DMD pathology in these translational models paves the way for new treatment approaches in patients with this devastating disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
36.130
5.856
64
100
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 1078-8956
e-ISSN 1546-170X
Zeitschrift Nature medicine
Quellenangaben Band: 26, Heft: 2, Seiten: 207-214 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Developmental Genetics (IDG)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF Topic(s) 30204 - Cell Programming and Repair
Forschungsfeld(er) Genetics and Epidemiology
Stem Cell and Neuroscience
PSP-Element(e) G-500500-001
G-506600-001
DOI 10.1038/s41591-019-0738-2
WOS ID WOS:000510552300002
Scopus ID 85078460427
PubMed ID 31988462
Erfassungsdatum 2020-03-26
[➜Korrektur melden]